Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Implantica presents the third quarter 2021 on November 24 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the third quarter 2021 at 15:00 CET on November 24. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: Conference call dial-in: · Sweden: +46 85-199 93 83 · United Kingdom: +44 3333 009030 · United States: +1-646-722-4902 Webcast: · https://tv.streamfabriken.com/implantica-q3-2021 Speakers: · CEO Peter Forsell · CFO Andreas Öhrnberg · VP Operations & IR Nicole Pehrsson For further

Prostatype Genomics presents Interim Report for the period 1 July to 30 September 2021

Prostatype Genomics presents Quarterly report for the third quarter of 2021. The Report is available on the Company's home page.Quarter 3 (1 July – 30 September 2021 compared with 1 July – 30 September 2020) summarized · Net sales amounted to 426 (556) TSEK. · Net revenue amounted to 0 (15) TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -3 613 (-3 555) TSEK. · Cash flow from current operations in the quarter amounted -3 831 (-3 782). · Total cash flow for the period amounted to 18 888 (-4 181) TSEK. · Earnings per share

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Nordea Bank AbpStock exchange release – Major shareholder announcements18 November 2021 at 9.00 EET Nordea Bank Abp has on 17 November 2021 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of 5 per cent on 16 November 2021. The total number of shares and voting rights in Nordea Bank Abp is 4,007,348,931. Total positions of BlackRock, Inc. and its funds according to the notification: %

Inzile AB (publ) Interim Report January 1 - September 30, 2021

Third quarter 2021 in brief • Revised agreement entered into regarding acquisition of 80% of QEV Tech Holdings • Acquisition of 80% of QEV Tech Holdings decided at Extraordinary General Meeting • Size of organization adapted to prevailing sales situation • Johan Svärd resigned as Chairman of the Board - replaced by Ragnar Åhgren • Four board members resigned - three new board members elected • Daniel Wedberg resigned as CEO - Klas Åhgren took over as acting CEO Third quarter 2021 in numbers • Net sales amounted to MSEK 0.92 (0.04) • Operating profit (EBIT)

MPC Container Ships Invest B.V. reports Q3 and nine-month 2021 results

Oslo/Rhoon, 18 November 2021 - MPC Container Ships Invest B.V. (the "Company", together with its subsidiaries the "Group") today published its unaudited financial report for the nine-month period ended 30 September 2021. The Group reported a net profit of USD 28.4 million for Q3 2021 (Q2 2021: net profit of USD 5.3 million). As at 30 September 2021, the Group owns 37 container vessels between 1,000 – 2,800 TEU. Further information and contact: ir@mpc-container.com About MPC Container Ships Invest B.V.: The Company was formed in September 2017 as a wholly-owned subsidiary of

SE - Stayble Therapeutics AB offentliggör kvartalsrapport för Q3 2021

Göteborg, 18 november 2021 – Stayble Therapeutics AB publicerar kvartalsrapport för tredje kvartalet (juli-september) 2021SammanfattningStayble Therapeutics AB redovisade rörelsekostnader om 3 049 (2 645) KSEK under perioden juli-september 2021. Väsentliga händelser under tredje kvartalet (juli-september 2021) · Inga väsentliga händelser som har en inverkan på Stayble Therapeutics finansiella ställning har skett under perioden. Väsentliga händelser efter periodens slut · Stayble Therapeutics presenterar interimsdata från pågående fas 2b-studie samt meddelar att

Metacon AB (publ) quarterly report Q3 2021

”During the third quarter focus was on key acquisitions in our core areas of green hydrogen and we received a breakthrough order in electrolysis”, says Christer Wikner, CEO Metacon AB (publ)CONSOLIDATED GROUP JULY 1 – SEPTEMBER 30, 2021 · Net sales amounted to 700 (491) kSEK · Operating result amounted to -8 147 (-6 983) kSEK · Result after financial items amounted to -8 158 (-7 056) kSEK · Result per share amounted to -0,03 SEK PARENT COMPANY JULY 1 – SEPTEMBER 30, 2021 · Net sales amounted to 83 (260) TSEK · Operating result amounted to -2 438 (-2 357) kSEK ·

Welcome to Wärtsilä’s Capital Markets Day 2021

Wärtsilä Corporation, Press release, 18 November 2021 at 09:00 AM EETWärtsilä hosts a Capital Markets Day for investors, analysts, and representatives from banks and media today at 13:00–16:30 EET. During the event, Wärtsilä’s President & CEO Håkan Agnevall together with members of the Board of Management will provide information on the company's business operations, the strategic themes of Transform and Perform, and the roadmap to reach the new financial targets announced on 17 November 2021. “We are on a journey of shaping the decarbonisation of the marine and energy industries. Going

Nightingale’s corporate health service piloted at Mitsui headquarters in Tokyo

Press release18 November 2021 at 9:00 (EET) Nightingale Health Japan KK, a fully owned subsidiary of Nightingale Health Plc (together “Nightingale”), is organising a pilot for its corporate health service at Japanese conglomerate Mitsui & Co Ltd. (“Mitsui”). The purpose of the pilot is to demonstrate how Nightingale’s wellbeing service can empower employees to take action to improve their daily lifestyle and develop better wellbeing with personal health information. The first phase of the pilot takes place on the 18[th] and 19[th] of November 2021, followed by the second phase in

TIE Kinetix Partners with EDI Support LLC to Maximize Customer Value via EDI Integration in Any ERP

TIE Kinetix , a leader in 100% supply chain digitalization, announced today that they have entered a strategic partnership with EDI Support LLC , a dedicated team of EDI experts that provide end-to-end EDI services and specialize in integration projects with any ERP. The partnership will drive long-term business success for TIE Kinetix and EDI Support customers looking to make their business processes more efficient.“Companies today want to streamline their operations as much as possible, but integration projects are incredibly

Interim report Q3: Continued strong organic growth and increased financial flexibility

July – September 2021 · Net sales increased with 119 % and amounted to SEK 506 (231) million. · Organic growth amounted to 23 (37) %. · Adjusted EBIT increased with 55 % to SEK 35 (23) million with a margin of 7.0 (9.8) %. · Profit for the period amounted to SEK 14 (10) million. · Earnings per share for the period before and after dilution amounted to SEK 0.42 (0.51). · After the end of the period, the company’s B shares were listed on Nasdaq Stockholm. In connection with the listing, a new share issue of SEK 500 million was made as well as an early redemption of the

Interim report January 1 – September 30, 2021

“In the third quarter of 2021, license revenue rose 37 percent and support revenue rose 12 percent. Overall, net sales rose 15 percent and operating loss totaled SEK -27 M (-29)”, says Johan Löf, CEO of RaySearch.THIRD QUARTER (JULY–SEPTEMBER 2021) · Order intake SEK 127.9 M (138.5) · Net sales SEK 136.4 M (119.1) · Operating loss SEK -26.6 M (-29.5) · Loss after tax SEK -22.0 M (-26.2) · Loss per share before/after dilution SEK -0.64 (-0.76) · Cash flow SEK -10.1 M (pos: 21.7) · Order backlog SEK 1,211.6 M (1,228.5) at the end of the period FIRST NINE MONTHS (

Aros Bostad signs agreement with Moelven and starts new residential project in Nacka

Aros Bostadsutveckling AB publ (”Aros Bostad”) has signed an agreement regarding a design and build contract with Moelven Byggmodul AB (”Moelven”), and thereby starts the construction of Ektorpsbacken in Nacka. The development project comprises totally 52 apartments, in a residential building which is constructed with wooden frames and facades.Magnus Andersson, CEO Aros Bostad says:”Ektorpsbacken is our fourth project in Nacka and our fifth development project to be started this year. We have awaited a new zoning plan for the area and it feels great to finally be able to start the project.

A letter from Daniel Harding – stays as Music Director of the Swedish Radio Symphony Orchestra until 2025

Daniel Harding extends his contract as Music Director and Artistic Director for the Swedish Radio Symphony Orchestra until at least 2025. "There is no doubt that here in Stockholm, in Berwaldhallen, I have found my musical family.  The bond between us is immense and the spark that we had at the start seems only brighter and more intense." A LETTER FROM DANIEL HARDINGSince the very beginning of my conducting career, I have been surrounded by musicians, collaborators and friends of exceptional generosity, talent and wisdom. I understood very early on that important and lasting

More than doubled order intake in the quarter

The third quarter: July – The nine-month period:September January – September · Net sales amounted to 243 · Net sales amounted to 797MSEK (258). MSEK (931). · Order intake increased 116 · Order intake increased 53percent to 306 MSEK (142). percent to 1,075 MSEK (703). · Order backlog increased 13 · Operating profit amountedpercent to 1,460 MSEK (1,294). to 80 MSEK (113). · Operating profit amounted · Adjusted operating profitto 24 MSEK (29). amounted to 81 MSEK (113). · Adjusted

Aker Horizons and Hanwha Solutions Join Forces in REC Silicon to Explore US Solar Value Chain Expansion

Aker Horizons ASA’s wholly owned subsidiary Aker Horizons Holding AS (“Aker Horizons”) has today entered into an agreement with South Korea’s Hanwha Solutions Corporation (“Hanwha Solutions”), one of the leading solar PV manufacturers in the US, and with REC Silicon ASA (“REC Silicon”).Hanwha Solutions will acquire 21,891,275 shares in REC Silicon from Aker Horizons and will subscribe for 48,213,001 new shares in REC Silicon through a private placement in REC Silicon. Both transactions are conditional upon each other and will be completed simultaneously, and are done at the same share price

SBB acquires approximately 35 percent of the shares and votes in Amasten and will after the completion of the acquisitions control in total approximately 53 percent of the shares and votes in Amasten

The potential Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the potential Offer, the distribution of this press release or the acceptance of any tender of shares in the potential Offer would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB” or the “Company”) has

Hexagon Purus to provide a leading provider of propulsion solutions with zero-emission trucks – continuing the drive toward zero-emission commercial transport

Hexagon Purus has been awarded a contract from a leading designer of hybrid electric and fully electric vehicle propulsion solutions, to deliver three battery electric trucks for testing of their next generation drivetrains. Hexagon Purus will provide fully integrated vehicle drivetrains including its proprietary ProPack[TM] high energy density battery pack, and power electronics for one Class 6 and two Class 8 trucks. The total sales value of the contract is approximately USD 1.7 million (approx. NOK 15 million). Driving energy transformation “This project involves us in the

DBP International: 20% of the shares of Bio Vitos is received

Double Bond Pharmaceutical International AB (publ) (“DBP”) is today able to confirm that it has received as agreed 10,010,000 (ten million and ten thousand) new ordinary shares of GBX 0.1 par value each of Bio Vitos, representing 20 (twenty) per cent of the issued share capital of Bio Vitos prior to the share issue to the Company in consideration for the previously-disclosed license over its intellectual property regarding ferrous succinate granted to Bio Vitos by DBP. A Confirmation Statement showing the share issuance was filed on Bio Vitos’ behalf with the Registrar of Companies in the

Nordic Nanovector ASA: Invitation to attend R&D Day

Oslo, Norway, 18 November 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical stage biotechnology company developing targeted radiopharmaceuticals to extend and improve the lives of patients with haematological cancers, will host an R&D Day on Tuesday, 30 November 2021 starting at 14:00 CET/ 13:00 GMT/ 08:00 ET. The meeting will be held in person in Oslo and will also be available via a live webcast. The meeting, intended for investors and analysts, will provide an overview of the company’s vision, progress to date, development pipeline and corporate strategy. Presentations will be

Nordic Nanovector ASA: Results for the Third Quarter 2021

Oslo, Norway, 18 November 2021 Nordic Nanovector ASA (OSE: NANOV) announces its results for the third quarter 2021. A presentation by Nordic Nanovector’s senior management team will be held in-person today in Oslo and webcast live beginning at 8:30am CET – details below. Erik Skullerud, CEO of Nordic Nanovector, said: “We are entering an exciting period for Nordic Nanovector, as the Company draws closer to completing patient recruitment for the PARADIGME trial, for which we expect readout of preliminary data in H1’ 2022. The Company is convinced that Betalutin® is uniquely positioned

First day to exercise Catena Media’s warrants (CTM TO1) for subscription of new shares during seventh exercise period

Catena Media plc (Nasdaq Stockholm: CTM)  Catena Media plc (“Catena Media” or “the company”) today announces that the seventh period to subscribe for shares in the company by exercise of warrants (ticker CTM TO1) (“the warrants”) commences today, 18 November 2021, and will run until and including 27 November 2021. During this period, each warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 18.90. Payment of subscribed shares can be made in cash or through set-off with the full nominal amount of each hybrid capital security (

Kungsleden renting to Vivaldi restaurant in Finnslätten, Västerås

Kungsleden’s Finnslätten cluster in Västerås is being developed to meet tomorrow’s needs and attract more high-tech companies to the area. Part of this venture includes expanding the range of services. Kungsleden is now renting 432 sq.m. in the Finnslätten 1 property to the Vivaldi restaurant, which is opening an Italian restaurant with a bakery and café. “Many of our tenants in Finnslätten are industry leaders. To help them become attractive employers and appeal to tomorrow’s talent, and to make Finnslätten an attractive location for more world-leading high-tech companies, the

Interim Report Q3, 2021

A quarter of deal making and regulatory review“Following on from the positive top line read out of Part A our Phase 3 study, we initiated a structured process to select our commercial partner for Nefecon in Europe. In this case, the result of the process was a partnership with Stada Arzneimittel, which has proven to be an excellent match. We also took the opportunity to complement our predominant source of equity capital with a $75m credit line from Kreos. In the third quarter, the U.S. Food and Drug Administration (FDA) requested further analyses of data from the NeflgArd clinical trial

There are no items matching the current filter
There are no more items matching the current filter
Back to top